본문 바로가기

Fabry nephropathy before and after enzyme replacement therapy: Important role of renal biopsy in patients with fabry disease

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q2Scopus Q1KCI Q2
저널
Kidney Research and Clinical Practice40(4) · pp.611 · 2021
피인용
Web of Science 12Scopus 13KCI 2
FWCI (Scopus)
1
JCR IF
JCR 2020 3.667
ISSN
2211-9132

저자

  1. 김일영제1저자Pusan Natl Univ, Dept Internal Med, Sch Med, Yangsan, South Korea
  2. 이현정Pusan Natl Univ, Dept Pathol, Sch Med, Yangsan, South Korea
  3. 전종근교신저자Pusan Natl Univ, Dept Pediat, Sch Med, Yangsan, South Korea

초록

© 2021 by The Korean Society of Nephrology.Background: In Fabry disease, the presence of globotriaosylceramide (GL3) deposits in various kidney cells leads to progressive renal dysfunction. However, kidney biopsy studies in patients with Fabry disease are limited. In the present study, the pathologic findings of patients with Fabry nephropathy receiving enzyme replacement therapy (ERT) and untreated patients without albuminuria were investigated. Methods: The present study included 15 patients with Fabry disease who underwent renal biopsy while receiving ERT (group 1: n = 9, age 19–58 years, two males and seven females) or before ERT initiation (group 2: n = 6, age 11–66 years, one male and five females). All patients in group 2 were normoalbuminuric. Results: Group 1 showed improved clinical symptoms, such as acroparesthesia. The ERT duration was 1.2 to 8 years and seven of the nine patients showed GL3 deposits in various kidney cells and segmental foot process effacement (FPE) of podocytes. GL3 deposits and FPE were not observed in the two remaining patients in group 1. Group 2 showed segmental FPE and podocyte GL3 deposits. Most patients in group 2 also showed GL3 deposits in the mesangium, endothelium, or tubular epithelium. Conclusion: The study results showed that segmental FPE and GL3 deposits can persist in Fabry nephropathy despite ERT. In addition, segmental FPE and GL3 deposits were observed in various kidney cells in normoalbuminuric patients with Fabry disease. These findings indicated that kidney biopsies at baseline and follow-up evaluation of Fabry nephropathy are essential for timely ERT initiation and ERT response assessment.

키워드

Enzyme replacement therapyFabry diseaseGlobotriaosylceramideNephropathyFOOT PROCESS EFFACEMENTAGALSIDASE ALPHAKIDNEYPATHOLOGYHISTOLOGYBETA

식별자

Scopus EID
2-s2.0-85121138316
WoS UID
000731356300010
KCI
ART002788812